This FAQ paper is a follow up to the webinar, Leveraging Microbial Contamination Monitoring Data for Actionable Insights to Meet and Exceed the Auditor’s Expectations. Questions submitted during and after the webinar are answered in this paper.
Compressed gases, such as nitrogen, carbon dioxide, and oxygen, are used for a variety of applications in pharmaceutical manufacturing. These applications, such as aseptic packaging, purging, and filtration, are critical processes monitored for their efficacy. To avoid sampling compressed gases, it has been speculated by some manufacturers that the rapid decompression of a gas when exiting its container kills any microbial contamination. However, it has been shown by multiple studies that microbial survival is not impacted by the typical compression or decompression seen in pharmaceutical process gases.
This application note breaks down the latest Annex 1 updates on cleanroom classification, qualification, and environmental monitoring. Learn what’s changed, what’s expected, and how to stay compliant in sterile manufacturing environments.
👉 Download the full guide to align your processes with Annex 1 Rev 12.